中文简体
中文繁体
English
ABOUT IASO
Overview
Management Team
Scientific Advisory Board
Partnership
SCIENCE & PRODUCTS
Publictaions
Technology Platforms
Pipeline
Manufacturing
Expanded Access
NEWS
Press Release
Media Report
CAREERS
Growth & Development
Working at IASO
Opportunities
CONTACT
NEWS
Press Release
Media Report
Search
12/08
2024
IASO Bio Receives U.S. FDA Approval Of Investigational New Drug Application For Equecabtagene Autoleucel For Two New Autoimmune Disease Indications
17/01
2023
IASO Bio Raises Nearly $75 Million in Series C1 Funding
23/09
2021
Fierce Biotech | China's IASO nets $108M to advance cell therapies, antibodies for cancer, autoimmune disease
12
2021-08
PRECISIOIN ONCOLOGY NEWS: In Brief This Week-IASO Biotherapeutics, Genentech, BioNTech
09
2021-06
Trailing the Big Pharma players, a lesser known BCMA CAR-T candidate comes into the spotlight
23
2019-11
IASO Bio to Present at ASH 2019
01
2019-09
IASO Bio to Present at IMWG 2019
01
2019-06
IASO Bio to Present at EHA
20
2019-05
IASO Bio to Present at ASCO 2019
09
2019-04
IASO Bio to Present at Global Summit on Hematologic Malignancies
1